NISHTHA GARG: Open Payments
NPI 1013505189 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 6 payments from 6 companies in 2025. Trend: 2023 $441 · 2024 $1,300 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $131 |
| Janssen Scientific Affairs, LLC | 1 | $127 |
| Astellas Pharma US Inc | 1 | $114 |
| ABIOMED | 1 | $107 |
| Amgen Inc. | 1 | $69 |
| ABBVIE INC. | 1 | $20 |
Products named: INGREZZA, TREMFYA, Veozah, EVENITY, QULIPTA.
Industry payments across FL — which companies pay providers there.
